PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 35 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

19 August 2025

  1. (diff | hist) m 09:54 Hypoglycaemia 4,417 ±0 LabRangeLindy (talk | contribs) add the note that titration exists partly to manage these effects [rollback]

18 August 2025

  1. (diff | hist) m 22:53 Counterfeit peptide 4,926 +673 TirzTaxonomist (talk | contribs) expand §Dilution with bulking agent [rollback]
  2. (diff | hist) 17:52 Shenzhen Hybio Pharmaceutical 2,847 +1,041 TallySheetTad (talk | contribs) alphabetise the see-also list [rollback]
  3. (diff | hist) m 17:50 Xi'an Mokemei Biotechnology 9,260 +294 CheckSumChase (talk | contribs) de-duplicate a repeated sentence [rollback]
  4. (diff | hist) 13:59 Baseline laboratory panel 4,429 +207 LipidLedgerLou (talk | contribs) fix a dangling clause [rollback]
  5. (diff | hist) 11:09 ISO 9001 3,898 ±0 Compounding_Cate (talk | contribs) expand §What the standard requires [rollback]
  6. (diff | hist) m b 08:26 Gastric emptying 5,565 +307 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  7. (diff | hist) 08:16 SURPASS trial programme 5,078 ±0 KPV_Kester (talk | contribs) expand §The head-to-head comparison [rollback]
  8. (diff | hist) m 08:09 High-performance liquid chromatography 6,815 ±0 SelectTrialSam (talk | contribs) rm the claim that the method is stability-indicating without a forced-degradation study [rollback]
  9. (diff | hist) m 07:43 International nonproprietary name 4,356 +356 TirzTaxonomist (talk | contribs) add see also to the amylin analogue [rollback]
  10. (diff | hist) 06:51 Wuhan Wansheng Biotechnology 14,048 ±0 VerifyVesna (talk | contribs) expand §Independent testing record [rollback]
  11. (diff | hist) 05:31 C-peptide 4,400 ±0 FerritinFay (talk | contribs) rm a duplicated category [rollback]
  12. (diff | hist) 05:28 GLP-1 receptor agonist 11,148 ±0 RetatrutideRuben (talk | contribs) add see also to the amylin analogue [rollback]

17 August 2025

  1. (diff | hist) m b 22:41 Proglucagon 6,709 ±0 ArchiveBot (talk | contribs) bot: expand PMID to full citation [rollback]
  2. (diff | hist) m b 20:25 Fmoc chemistry 4,618 ±0 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  3. (diff | hist) m 18:54 Aspiration risk under anaesthesia 4,681 +304 Areapercent_Ayo (talk | contribs) add the pregnancy statement as attributed to the labelling [rollback]
  4. (diff | hist) 17:28 Active pharmaceutical ingredient 4,355 ±0 GreyMarketGreer (talk | contribs) expand §The regulatory frame [rollback]
  5. (diff | hist) 12:40 Sterile water for injection 4,738 ±0 SafetySignalSid (talk | contribs) correct the unit conversion — U-100 not U-40 [rollback]
  6. (diff | hist) m b 11:29 Enteroendocrine L cell 5,083 ±0 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  7. (diff | hist) 09:16 GLP-1 receptor 7,570 ±0 EmptyingElke (talk | contribs) distinguish the active and total forms of the hormone throughout [rollback]

16 August 2025

  1. (diff | hist) m 19:30 GL Biochem (Shanghai) 15,340 +798 BlankVialBo (talk | contribs) fix hyphenation per PP:MOS [rollback]
  2. (diff | hist) m b 18:36 Residual solvent 4,819 ±0 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  3. (diff | hist) 11:33 Talk:Shenzhen Hybio Pharmaceutical 1,033 +196 ScopeSeverin (talk | contribs) /* Notability, and what a long registry record does not establish */ reply
  4. (diff | hist) 09:31 Grey market 3,495 ±0 RfC_Rasmus (talk | contribs) add the excursion tolerance with the study it derives from [rollback]
  5. (diff | hist) 07:54 Bacteriostatic water 4,652 ±0 StabilityStig (talk | contribs) give the worked example to two significant figures throughout [rollback]
  6. (diff | hist) 03:50 Deamidation 4,961 ±0 TesamorelinTeg (talk | contribs) state the mass accuracy in parts per million rather than daltons [rollback]
  7. (diff | hist) 02:57 Sigma-Aldrich (Shanghai) Trading 12,137 +1,265 LeaderLoic (talk | contribs) add short description [rollback]
  8. (diff | hist) 02:35 Personal importation policy 3,797 ±0 DeadSpaceDot (talk | contribs) add the year the guidance was issued [rollback]
  9. (diff | hist) 01:20 Liraglutide 5,967 ±0 OrforglipronOona (talk | contribs) rm the comparison to a compound with no published head-to-head data [rollback]

15 August 2025

  1. (diff | hist) m 14:36 Placebo-adjusted effect 4,581 ±0 ITT_Imelda (talk | contribs) add the discontinuation rate for adverse events in both arms [rollback]
  2. (diff | hist) 13:13 Shenzhen Hybio Pharmaceutical 1,806 ±0 MOTSc_Mira (talk | contribs) expand the product-scope row in the infobox [rollback]
  3. (diff | hist) 11:42 Talk:Research use only 1,307 +64 FiveOhThreeB (talk | contribs) /* Do we state the position for any named jurisdiction? */ reply
  4. (diff | hist) 10:44 Janoshik Analytical 5,235 ±0 PuffRemoverPax (talk | contribs) expand §What the reports contain [rollback]
  5. (diff | hist) 08:51 Shanghai ERP Biotechnology 5,367 +1,347 StubExpanderSven (talk | contribs) add the research-use-only statement to the lead rather than only the footer [rollback]
  6. (diff | hist) 08:05 Talk:Karl Fischer titration 822 +100 SigFigSindri (talk | contribs) /* Worked example — is the arithmetic order right? */ reply
  7. (diff | hist) 02:39 Bachem Holding (Suzhou) 12,934 ±0 CheckSumChase (talk | contribs) fix a broken wikilink [rollback]

14 August 2025

  1. (diff | hist) 19:43 Multi-dose vial 18,736 +539 A1c_Alder (talk | contribs) de-orphan [rollback]
  2. (diff | hist) N 18:47 Shenzhen Hybio Pharmaceutical 1,806 +1,806 TelehealthTruus (talk | contribs) start organisation article — registry facts and product scope only
  3. (diff | hist) 18:26 Vial filling and stoppering 4,557 ±0 MolarMassMaeve (talk | contribs) correct the freezer temperature range given for long-term storage [rollback]
  4. (diff | hist) 12:11 Analytical method validation 5,342 ±0 HalfLifeHavel (talk | contribs) correct the water-content figure — the source reports it on a dry basis [rollback]
  5. (diff | hist) 11:38 Talk:Karl Fischer titration 611 +327 AnalyticalAnnie (talk | contribs) /* Worked example — is the arithmetic order right? */ reply
  6. (diff | hist) 10:05 Talk:Shenzhen Hybio Pharmaceutical 822 +320 COA_Colwyn (talk | contribs) /* Notability, and what a long registry record does not establish */ reply
  7. (diff | hist) 09:12 Talk:Karl Fischer titration 400 +347 SigFigSindri (talk | contribs) /* Worked example — is the arithmetic order right? */ new section
  8. (diff | hist) 09:08 Talk:Research use only 1,096 +197 GMP_Gita (talk | contribs) /* Do we state the position for any named jurisdiction? */ reply
  9. (diff | hist) m 06:38 Limit of detection 4,550 ±0 Retention_Time_Rae (talk | contribs) add the reference standard and its traceability [rollback]
  10. (diff | hist) 02:41 Oral semaglutide 4,349 ±0 CagriCass (talk | contribs) rm the comparison to a compound with no published head-to-head data [rollback]
  11. (diff | hist) 01:26 Certificate of analysis 9,814 +365 Chromatokid (talk | contribs) clarify that agreement between certificate and report is a weak finding [rollback]

13 August 2025

  1. (diff | hist) 23:46 Dose escalation schedule 4,682 ±0 MissedDoseMik (talk | contribs) add category for preparation and handling [rollback]
  2. (diff | hist) 22:36 Hubei Jianxiang Bioscience 8,536 +489 Chromatokid (talk | contribs) rm the price; supplier articles carry no price per PP:VN [rollback]
  3. (diff | hist) m 22:35 USP General Chapter 85 4,920 +625 AnalyticalAnnie (talk | contribs) clarify that mass spectrometry confirms identity, not purity [rollback]
  4. (diff | hist) m 22:14 Lixisenatide 4,195 +138 CagriCass (talk | contribs) rm a duplicated category [rollback]
  5. (diff | hist) 15:31 Talk:Research use only 885 +217 Compounding_Cate (talk | contribs) /* Do we state the position for any named jurisdiction? */ reply
  6. (diff | hist) m 14:10 Tirzepatide 8,037 ±0 SiteReactionSuz (talk | contribs) fix a broken wikilink [rollback]
  7. (diff | hist) 12:48 Talk:Shenzhen Hybio Pharmaceutical 611 +297 Hedgerow_Hal (talk | contribs) /* Notability, and what a long registry record does not establish */ reply
  8. (diff | hist) 11:06 Haemoglobin A1c 4,243 +147 PanelPlannerPam (talk | contribs) add the standardisation programme the assay is traceable to [rollback]
  9. (diff | hist) 10:55 Talk:Research use only 674 +187 FiveOhThreeB (talk | contribs) /* Do we state the position for any named jurisdiction? */ new section
  10. (diff | hist) 10:00 Dipeptidyl peptidase-4 7,022 ±0 TitrationTheo (talk | contribs) clarify that the receptor is expressed outside the pancreas [rollback]
  11. (diff | hist) 09:20 Talk:Shenzhen Hybio Pharmaceutical 400 +591 ScopeSeverin (talk | contribs) /* Notability, and what a long registry record does not establish */ new section
  12. (diff | hist) m 09:16 Trifluoroacetate counterion 4,865 ±0 DiffWatchDov (talk | contribs) add short description [rollback]

12 August 2025

  1. (diff | hist) m b 12:38 Underfilling 4,674 +782 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  2. (diff | hist) 12:18 Peptide synthesis 4,967 ±0 AnalyticalAnnie (talk | contribs) add the crimp-seal step to the fill-and-finish description [rollback]
  3. (diff | hist) m b 10:50 Custom peptide synthesis 4,773 +225 ArchiveBot (talk | contribs) bot: normalise unit spacing [rollback]
  4. (diff | hist) m b 09:17 Peptide harm reduction 4,630 ±0 StubSorterBot (talk | contribs) bot: normalise currency formatting [rollback]

11 August 2025

  1. (diff | hist) m b 22:21 Subcutaneous injection 5,293 +653 CategoryBot (talk | contribs) bot: add stub category [rollback]
  2. (diff | hist) 19:22 Missed dose 5,277 +246 Chromatokid (talk | contribs) clarify that the figure is per dose, not per vial [rollback]
  3. (diff | hist) 17:41 Reconstitution of lyophilised peptides 5,761 ±0 PatientPanelPru (talk | contribs) state that reconstituted material should not be frozen, with the source [rollback]
  4. (diff | hist) 10:54 Medutest 4,669 ±0 CheckSumChase (talk | contribs) fix indentation in the source [rollback]
  5. (diff | hist) 10:51 SinoPep 5,978 ±0 TierTwoTansy (talk | contribs) close an unbalanced quotation mark [rollback]
  6. (diff | hist) 10:13 Body composition assessment 4,901 ±0 FerritinFay (talk | contribs) add the note that a single value out of range is not a finding [rollback]
  7. (diff | hist) m 05:17 Retention time 3,764 ±0 PeakShapePol (talk | contribs) add the plate-count expression and define its terms [rollback]

10 August 2025

  1. (diff | hist) m 21:10 Satiety signalling 5,593 +348 ArcuateArt (talk | contribs) add see also to the sister hormone [rollback]
  2. (diff | hist) m 18:21 Qingdao Sigma Chemical 13,668 +798 TallySheetTad (talk | contribs) expand §Product range [rollback]
  3. (diff | hist) 16:51 Third-party testing 7,489 +583 DulaglutideDug (talk | contribs) add the laboratory accreditation status, or say plainly that it is not stated [rollback]
  4. (diff | hist) 14:12 Prior authorisation 4,081 ±0 ReaderRosalie (talk | contribs) state whether the figure is list price or net of rebate [rollback]
  5. (diff | hist) 13:27 Temperature excursion 13,899 +485 AppealsArno (talk | contribs) expand §Labelled allowances and in-use periods [rollback]
  6. (diff | hist) m 12:45 SELECT trial 5,171 +320 DataTableDunja (talk | contribs) rm the cross-trial comparison; the populations are not comparable [rollback]
  7. (diff | hist) 09:23 PeptideMeter 4,694 ±0 CheckSumChase (talk | contribs) add category for certificates of analysis [rollback]
  8. (diff | hist) 08:24 Vial 22,966 +522 PrepHPLC_Pia (talk | contribs) add the crimp-seal step to the fill-and-finish description [rollback]
  9. (diff | hist) 07:08 Insulin secretion 6,940 ±0 BetaCellBoyd (talk | contribs) add the cleavage site by residue number [rollback]

9 August 2025

  1. (diff | hist) m 21:12 Resin cleavage 4,029 ±0 StopperingSteff (talk | contribs) clarify that the cake appearance is an indicator, not a specification [rollback]
  2. (diff | hist) 18:30 Lot traceability 5,087 ±0 ReportReaderRilla (talk | contribs) add the point that reports reaching this wiki are not a sample of anything [rollback]
  3. (diff | hist) 15:55 Qingdao Saber Technology Pharmaceutical 5,550 +201 BlankVialBo (talk | contribs) add category for suppliers in China [rollback]
  4. (diff | hist) 15:42 Beyond-use date 18,154 +989 GramsNotUnitsGil (talk | contribs) fix a dangling clause [rollback]
  5. (diff | hist) 12:45 SUSTAIN trial programme 5,153 +425 TallySheetTad (talk | contribs) fix a broken wikilink [rollback]
  6. (diff | hist) m 12:22 Test report forgery 5,055 ±0 PanelPlannerPam (talk | contribs) expand §Forms and their detectability [rollback]
  7. (diff | hist) 07:59 Purity claim inflation 5,442 ±0 Chromatokid (talk | contribs) state that the report identifies the sample, not the shipment [rollback]

8 August 2025

  1. (diff | hist) 21:11 Shanghai ERP Biotechnology 4,020 +33 ChainCustodyChad (talk | contribs) add the storage and handling guidance the organisation publishes [rollback]
  2. (diff | hist) m 20:39 Cost per milligram 4,027 ±0 LotTraceLuka (talk | contribs) rm the telehealth provider name; the article describes the model, not the vendors [rollback]
  3. (diff | hist) 18:58 ChinaPeptides 12,507 +528 DEXA_Dilys (talk | contribs) state the city and province of the registered address [rollback]
  4. (diff | hist) 17:20 Amylin receptor agonist 4,965 ±0 Peptide_Pete (talk | contribs) add see also to the amylin analogue [rollback]
  5. (diff | hist) 15:27 Trial data comparison 5,803 +182 MOTSc_Mira (talk | contribs) expand §Why the estimand matters [rollback]
  6. (diff | hist) m 13:46 Fasting insulin 4,198 +288 BaselineBex (talk | contribs) expand §Why it needs glucose alongside it [rollback]
  7. (diff | hist) m b 12:14 Chain of custody 5,022 ±0 ArchiveBot (talk | contribs) bot: update parent category chain [rollback]
  8. (diff | hist) m 11:57 WuXi TIDES 14,644 +798 EndotoxinEd (talk | contribs) copyedit [rollback]
  9. (diff | hist) 11:35 Talk:Tianjin Finder Chemical 1,170 +178 BalanceBirdie (talk | contribs) /* Certificate date and dispatch date */ reply
  10. (diff | hist) m 10:37 Chinese Peptide Company 13,887 +798 ChainCustodyChad (talk | contribs) add the minimum order quantity for custom synthesis [rollback]
  11. (diff | hist) 08:59 HOMA-IR 4,218 ±0 DEXA_Dilys (talk | contribs) correct the analyte name to the recommended nomenclature [rollback]
  12. (diff | hist) m 02:39 Amino acid analysis 4,068 ±0 TFA_Counterion (talk | contribs) fix a dangling clause [rollback]

7 August 2025

  1. (diff | hist) 19:12 Dulaglutide 5,490 +360 ComparisonCato (talk | contribs) correct the molar mass — source gives the free-base figure, we had the salt [rollback]
  2. (diff | hist) 13:32 Bacterial endotoxin test 5,088 ±0 CRP_Cormac (talk | contribs) add the ionisation mode to the mass-spectrometry description [rollback]